戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ve lumbar nerve blocks with triamcinolone or betamethasone.
2 ng volumes for two, three, and four doses of betamethasone.
3 volume after fetal exposure to four doses of betamethasone.
4 ncreased risk of neonatal hypoglycemia after betamethasone.
5 ive dose was equivalent to 15 (IQR 10-19) mg betamethasone.
6         The patient was treated with topical betamethasone 0.1% six times daily and oral acyclovir 40
7               Nasal irrigation (240 mL) with betamethasone, 1 mg, or budesonide, 1 mg, daily for 3 to
8 d dexamethasone 4-9 mg/day for 3-19 weeks or betamethasone 12-24 mg/week for >6 weeks (group A).
9 rse were randomly assigned to receive either betamethasone, 12 mg intramuscularly repeated once in 24
10  course of antenatal corticosteroids (either betamethasone, 12 mg intramuscularly repeated once in 24
11               First, the in vitro release of betamethasone-17-valerate (BMV), a representative dermat
12 Of 2831 children, 1026 enrolled and 949 (479 betamethasone, 470 placebo) completed the DAS-II at a me
13 e patients received a mixture of 1 mL of the betamethasone, 6 mg/mL, and 1 mL of 0.5% bupivacaine hyd
14 ture of betamethasone-phosphate (Beta-P) and betamethasone-acetate (Beta-Ac) - the clinical drug.
15                      It is not known whether betamethasone administered to women at risk for late pre
16           Twelve milligrams of intramuscular betamethasone administered twice 24 hours apart.
17       The association of time from antenatal betamethasone administration to birth with neonatal surv
18                  Time in hours from anenatal betamethasone administration to birth.
19 ys) were included in the cohort: 475 with no betamethasone and 1331 with exposure to a single dose of
20 drift-times for the protonated diastereomers betamethasone and dexamethasone are reproducibly differe
21                                         Both betamethasone and dexamethasone induce similar increases
22 cific differences, if any, in the actions of betamethasone and dexamethasone of measured fetal respon
23           Our results indicate that prenatal betamethasone and dexamethasone treatment of late-gestat
24           The fall in fetal breathing during betamethasone and dexamethasone treatment was not associ
25 fetal blood pressure occurred following both betamethasone and dexamethasone treatment.
26 nd adrenaline concentrations occurred during betamethasone and dexamethasone treatment.
27 ts of fetal treatment with clinical doses of betamethasone and dexamethasone; (2) define specific dif
28 ric changes in the lungs of lambs exposed to betamethasone and T4 48 h before preterm delivery at 121
29             Selective nerve root blocks with betamethasone and triamcinolone reduced low back pain an
30                     Corticosteroids (such as betamethasone) and magnesium sulphate (MgSO4) are admini
31 d 76% at 2 weeks with vehicle, pimecrolimus, betamethasone, and clobetasol, respectively, with parall
32 e with breast cancer, Hydrofilm, mometasone, betamethasone, and olive oil.
33 isrupted serotonin signalling and identified betamethasone as a drug which normalises the excessive d
34  the United States by finding that antenatal betamethasone at 34 to 36 weeks decreased short-term neo
35 domized to receive saline (controls) or 6 mg betamethasone (beta) 48 and 24 h before delivery at 125
36 ticoids mostly used, Dexamethasone (Dex) and Betamethasone (Beta), are unknown.
37 flexion spasms based on prenatal exposure to betamethasone combined with postnatal administration of
38                Prenatal treatment with MgSO4/betamethasone confers long-term benefits beyond cerebral
39  were randomly assigned to weekly courses of betamethasone, consisting of 12 mg given intramuscularly
40 xpectedly high percentage of those receiving betamethasone-containing dermatologic preparations had d
41 ibavirin and interferon alfa-2b, and various betamethasone-containing dermatologic preparations.
42                    Topical administration of betamethasone did not improve rhinosinusitis and olfacto
43  a similar extent as a positive control 0.1% betamethasone dipropionate ointment.
44 igator site daily for 14 days: pimecrolimus, betamethasone dipropionate, clobetasol propionate, and a
45                                     Prenatal betamethasone exposure sensitizes rats to development of
46 12/group) that were chronically treated with betamethasone (glucocorticoid receptor agonist) or vehic
47 s farinae were divided into six groups: 1) a betamethasone group (betamethasone ointment, six times a
48 curred in 165 of 1427 infants (11.6%) in the betamethasone group and 202 of 1400 (14.4%) in the place
49 Neonatal hypoglycemia was more common in the betamethasone group than in the placebo group (24.0% vs.
50 ) in the placebo group (relative risk in the betamethasone group, 0.80; 95% confidence interval [CI],
51 ccurred significantly less frequently in the betamethasone group.
52 neonatal hypoglycemia was more common in the betamethasone group.
53  as follows: triamcinolone > dexamethasone > betamethasone > hydrocortisone.
54  lubricating gel and drops, chloramphenicol, betamethasone, homatropine, oral vitamin C, and doxycycl
55 emonstrated that antenatal administration of betamethasone in the late preterm period (between 34 to
56                               The pronounced betamethasone-induced fetal hypertension is associated w
57 fants exposed to multiple doses of antenatal betamethasone, infants who did not receive intensive car
58   Following baseline, either saline (n = 9), betamethasone (n = 9), or dexamethasone (n = 6) was infu
59  significantly improved as compared with the betamethasone ointment and placebo groups.
60 ally, three times a week), 3) an FTY720 plus betamethasone ointment group, 4) an ointment base group
61                           In the FTY720 plus betamethasone ointment group, the dermatitis was signifi
62  suggest that the combination of FTY720 plus betamethasone ointment is a promising candidate for trea
63 d into six groups: 1) a betamethasone group (betamethasone ointment, six times a week), 2) an FTY720
64          Pregnant rats received two doses of betamethasone on day 15 of gestation.
65  occurred during fetal treatment with either betamethasone or dexamethasone.
66 s were assigned to receive two injections of betamethasone or matching placebo 24 hours apart.
67 domized to receive 1 to 4 doses of 0.5 mg/kg betamethasone or saline placebo at 7 d intervals from 10
68  two intramuscular doses of a 1:1 mixture of betamethasone-phosphate (Beta-P) and betamethasone-aceta
69 , 42% of triamcinolone recipients and 58% of betamethasone recipients demonstrated improvement in low
70 , 42% of triamcinolone recipients and 53% of betamethasone recipients had improvement in low back pai
71 , 45% of triamcinolone recipients and 58% of betamethasone recipients had improvement in low back pai
72 s 49% of triamcinolone recipients and 55% of betamethasone recipients had improvement in lower extrem
73 s 52% of triamcinolone recipients and 57% of betamethasone recipients had improvement in lower extrem
74 s 55% of triamcinolone recipients and 57% of betamethasone recipients had lower extremity pain improv
75  the timing from administration of antenatal betamethasone to birth may reduce mortality and morbidit
76                            Administration of betamethasone to women at risk for late preterm delivery
77        Lung function for six control and six betamethasone-treated animals was similar.
78                                              Betamethasone treatment had little effect, confirming th
79 ive femoral vasoconstriction occurred during betamethasone treatment.
80 tion and the effectiveness of prenatal MgSO4/betamethasone treatments between males and females in a
81                              Three steroids (betamethasone, triamcinolone, and methylprednisolone) an
82                      We recently showed that betamethasone valerate (BM) although clinically more eff
83                                       Unlike betamethasone valerate (BMV), long-term NF-kappaB Decoy
84  (Fingolimod), alone and in combination with betamethasone valerate ointment, in the NC/Nga mouse mod
85                                              Betamethasone valerate resulted in a significant reducti
86 than 85, which occurred in 82 (17.1%) of the betamethasone vs 87 (18.5%) of the placebo group (adjust
87 rval for infants born after a single dose of betamethasone was 3.8 (1.4-9.5) hours.
88 even short duration of exposure to antenatal betamethasone was associated with improved neonatal surv
89 ne, boldenone, trenbolone, testosterone, and betamethasone were chosen as study compounds.
90 e and 1331 with exposure to a single dose of betamethasone within 24 hours before birth.